No results found for your search: Liver Disease Startups.

No results were found for Liver Disease Startups, but we've selected some related recommendations for you.

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 9 start-ups with an aggregate funding of $523.7m. The average funding per company in this subset is $58.2m.

Last update to the database: Feb 18, 2025. See changelog.

See all results for this search

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up
Promethera Biosciences logo

Promethera Biosciences

5

Funding Rounds

$103.1m

Money raised

Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.

Industries:

Immunotherapy Healthcare Regenerative medicine

Location:

Belgium Durham, North Carolina Mont-Saint-Guibert

Key people:

Inipharm logo

Inipharm

1

Funding Rounds

$35.0m

Money raised

Inipharm is a company developing liver disease therapies.

Industries:

Engineering Biomedical engineering Technology

Location:

San Diego

Key people:

Enyo Pharma logo

Enyo Pharma

2

Funding Rounds

$97.5m

Money raised

Develops small molecules drug candidates in infectious & metabolic diseases and oncology

Industries:

Fashion Enterprise software Biomedical engineering

Location:

Lyon

Key people:

Pandorum Technologies logo

Pandorum Technologies

4

Funding Rounds

$9.7m

Money raised

Pandorum Technologies Pvt. Ltd. is a Bangalore-based biotechnology company with a focus on tissue engineering and regenerative medicine.

Industries:

Liver disease Healthcare Biopharmaceutical

Location:

Karnataka San Carlos, California Bangalore

Key people:

Ochre Bio logo

Ochre Bio

4

Funding Rounds

$49.4m

Money raised

Ochre Bio is a biotechnology platform focused on rejuvenating transplant livers founded in 2019 by Jack O'Meara.

Industries:

Biotechnology Biopharmaceutical Drug discovery

Location:

Oxford

Key people:

AgomAb (Company) logo

AgomAb (Company)

2

Funding Rounds

$97.6m

Money raised

Agonistic monoclonal antibody molecules

Industries:

Liver disease Engineering Biomedical engineering

Location:

Ghent
Ocelot Bio logo

Ocelot Bio

1

Funding Rounds

$36.0m

Money raised

Peptide therapeutic to treat complications of end-stage liver disease

Industries:

Liver disease Biotechnology Biopharmaceutical

Location:

San Diego
Alentis Therapeutics logo

Alentis Therapeutics

2

Funding Rounds

$79.5m

Money raised

Alentis Therapeutics is a monoclonal Antibody.

Industries:

Liver disease Biotechnology Biomedical engineering

Location:

Switzerland
Versantis logo

Versantis

1

Funding Rounds

$16.0m

Money raised

Versantis is a Switzerland-based company.

Industries:

Liver disease

Location:

Switzerland

Sign up to access our full database

Enter your email and get access to 71,000 + technology companies you can partner with.

Join 29000+ founders, operators, and investors.